Summary of Dosimetric Gy/GBq Values of 131I-BA52 Estimated for Organs and Tumor Lesions
| Organ | Dose (Gy/GBq) |
| Adrenals | 0.35 |
| Brain | 0.19 |
| Breasts | 0.24 |
| Gallbladder wall | 0.43 |
| Lower large intestine wall | 3.10 |
| Small intestine | 0.39 |
| Stomach wall | 0.30 |
| Upper large intestine wall | 4.64 |
| Heart wall | 0.36 |
| Kidneys | 0.30 |
| Liver | 1.30 |
| Lungs | 3.15 |
| Muscle | 0.25 |
| Ovaries | 0.36 |
| Pancreas | 0.34 |
| Red marrow | 0.20 |
| Osteogenic cells | 0.40 |
| Skin | 0.19 |
| Spleen | 0.59 |
| Testes | 0.19 |
| Thymus | 0.29 |
| Thyroid | 0.23 |
| Urinary bladder wall | 0.66 |
| Uterus | 0.30 |
| Total body | 0.33 |
| Effective dose equivalent | 0.99 |
| Effective dose | 0.92 |
| Eyes | |
| Ciliary body | 5.7–15.4 |
| Choroid | 8.1 |
| Retina | 2.7 |
| Melanoma metastases | |
| Mean ± SD | 5.5 ± 3.6 |
| Range | 1.13–12.2 |